Pathophysiologic and Therapeutic Perspectives Based on Thrombus Histology in Stroke

키워드

참고문헌 (73)

1. Goyal M, "Endovascular thrombectomy after largevessel ischaemic stroke : a meta-analysis of individual patient data from five randomised trials", Lancet, 387, pp.1723~1731 (2016)
2. Tommy Andersson, "The Aspirations of Direct Aspiration for Thrombectomy in Ischemic Stroke: A Critical Analysis", 대한뇌졸중영문학회지, 21(1), pp.2~9 (2019), 대한뇌졸중학회[DOI]
3. Sang-Bae Ko, "2019 Update of the Korean Clinical Practice Guidelines of Stroke for Endovascular Recanalization Therapy in Patients with Acute Ischemic Stroke", 대한뇌졸중영문학회지, 21(2), pp.231~240 (2019), 대한뇌졸중학회[DOI]
4. Powers WJ, "Guidelines for the early management of patients with acute ischemic stroke : 2019 update to the 2018 guidelines for the early management of acute ischemic stroke : a guideline for healthcare professionals from the American heart association", American stroke association, 2019, pp.50, e344~e418
5. Jong-Won Chung, "Selection of Candidates for Endovascular Treatment: Characteristics According to Three Different Selection Methods", 대한뇌졸중영문학회지, 21(3), pp.332~339 (2019), 대한뇌졸중학회[DOI]
6. Brinjikji W, "Correlation of imaging and histopathology of thrombi in acute ischemic stroke with etiology and outcome : a systematic review", J Neurointerv Surg, 9, pp.529~534 (2017)
7. 허지회, "Computed Tomography-Based Thrombus Imaging for the Prediction of Recanalization after Reperfusion Therapy in Stroke", 대한뇌졸중영문학회지, 19(1), pp.40~49 (2017), 대한뇌졸중학회
8. De Meyer SF, "Analyses of thrombi in acute ischemic stroke : a consensus statement on current knowledge and future directions", Int J Stroke, 12, pp.606~614 (2017)
9. Marder VJ, "Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke", Stroke, 37, pp.2086~2093 (2006)
10. Liebeskind DS, "CT and MRI early vessel signs reflect clot composition in acute stroke", Stroke, 42, pp.1237~1243 (2011)
11. Niesten JM, "Histopathologic composition of cerebral thrombi of acute stroke patients is correlated with stroke subtype and thrombus attenuation", PLoS One, 9, pp.e88882~ (2014)
12. Kim SK, "Histologic analysis of retrieved clots in acute ischemic stroke : correlation with stroke etiology and gradient-echo MRI", AJNR Am J Neuroradiol, 36, pp.1756~1762 (2015)
13. Ahn SH, "Histologic features of acute thrombi retrieved from stroke patients during mechanical reperfusion therapy", Int J Stroke, 11, pp.1036~1044 (2016)
14. Boeckh-Behrens T, "Thrombus histology suggests cardioembolic cause in cryptogenic stroke", Stroke, 47, pp.1864~1871 (2016)
15. Sporns PB, "Ischemic stroke : histological thrombus composition and pre-interventional ct attenuation are associated with intervention time and rate of secondary embolism", Cerebrovasc Dis, 44, pp.344~350 (2017)
16. Maekawa K, "Erythrocyte-rich thrombus is associated with reduced number of maneuvers and procedure time in patients with acute ischemic stroke undergoing mechanical thrombectomy", Cerebrovasc Dis Extra, 8, pp.39~49 (2018)
17. Boeckh-Behrens T, "The impact of histological clot composition in embolic stroke", Clin Neuroradiol, 26, pp.189~197 (2016)
18. Sato Y, "Thrombus components in cardioembolic and atherothrombotic strokes", Thromb Res, 130, pp.278~280 (2012)
19. Sporns PB, "Ischemic stroke: what does the histological composition tell us about the origin of the thrombus?", Stroke, 48, pp.2206~2210 (2017)
20. Schuhmann MK, "Immunohistochemical analysis of cerebral thrombi retrieved by mechanical thrombectomy from patients with acute ischemic stroke", Int J Mol Sci, 17, pp.298~ (2016)
21. Dargazanli C, "High CD3+ cells in intracranial thrombi represent a biomarker of atherothrombotic stroke", PLoS One, 11, pp.e0154945~ (2016)
22. Laridan E, "Neutrophil extracellular traps in ischemic stroke thrombi", Ann Neurol, 82, pp.223~232 (2017)
23. Nosaka M, "Time-dependent appearance of intrathrombus neutrophils and macrophages in a stasis-induced deep vein thrombosis model and its application to thrombus age determination", Int J Legal Med, 123, pp.235~240 (2009)
24. Navi BB, "Risk of arterial thromboembolism in patients with cancer", J Am Coll Cardiol, 70, pp.926~938 (2017)
25. Park H, "Histological features of intracranial thrombi in stroke patients with cancer", Ann Neurol, 86, pp.143~149 (2019)
26. Biller J, "Nonbacterial thrombotic endocarditis. A neurologic perspective of clinicopathologic correlations of 99 patients", Arch Neurol, 39, pp.95~98 (1982)
27. Rogers LR, "Cerebral infarction from non-bacterial thrombotic endocarditis. Clinical and pathological study including the effects of anticoagulation", Am J Med, 83, pp.746~756 (1987)
28. Navi BB, "Recurrent thromboembolic events after ischemic stroke in patients with cancer", Neurology, 83, pp.26~33 (2014)
29. Graus F, "Cerebrovascular complications in patients with cancer", Medicine(Baltimore), 64, pp.16~35 (1985)
30. Martinod K, "Thrombosis : tangled up in NETs", Blood, 123, pp.2768~2776 (2014)
31. Fuchs TA, "Extracellular DNA traps promote thrombosis", Proc Natl Acad Sci U S A, 107, pp.15880~15885 (2010)
32. Laridan E, "Neutrophil extracellular traps in arterial and venous thrombosis", Semin Thromb Hemost, 45, pp.86~93 (2019)
33. Ducroux C, "Thrombus neutrophil extracellular traps content impair tpa-induced thrombolysis in acute ischemic stroke", Stroke, 49, pp.754~757 (2018)
34. Rittersma SZ, "Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis : a pathological thrombectomy study in primary percutaneous coronary intervention", Circulation, 111, pp.1160~1165 (2005)
35. Rashidi A, "Lines of Zahn in the splenic vein", Thromb Haemost, 118, pp.957~958 (2018)
36. Khan AA, "The prothrombotic state in atrial fibrillation : pathophysiological and management implications", Cardiovasc Res, 115, pp.31~45 (2019)
37. Jamasbi J, "Platelet receptors as therapeutic targets: past, present and future", Thromb Haemost, 117, pp.1249~1257 (2017)
38. Nieswandt B, "Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke", J Thromb Haemost, 9(Suppl 1), pp.92~104 (2011)
39. Badimon L, "Thrombosis formation on atherosclerotic lesions and plaque rupture", J Intern Med, 276, pp.618~632 (2014)
40. 김경섭, "Histopathological Findings of Intracranial Thrombi in Nonbacterial Thrombotic Endocarditis", 대한뇌졸중영문학회지, 19(3), pp.367~369 (2017), 대한뇌졸중학회
41. Jurasz P, "Platelet : cancer interactions : mechanisms and pharmacology of tumour cellinduced platelet aggregation", Br J Pharmacol, 143, pp.819~826 (2004)
42. Egan K, "Living in shear : platelets protect cancer cells from shear induced damage", Clin Exp Metastasis, 31, pp.697~704 (2014)
43. Mitrugno A, "A novel and essential role for FcγRIIa in cancer cell-induced platelet activation", Blood, 123, pp.249~260 (2014)
44. Singh P, "Immunohistochemical analysis of thrombi retrieved during treatment of acute ischemic stroke: does stent-retriever cause intimal damage?", Stroke, 44, pp.1720~1722 (2013)
45. Shin JW, "High red blood cell composition in clots is associated with successful recanalization during intra-arterial thrombectomy", PLoS One, 13, pp.e0197492~ (2018)
46. Hashimoto T, "Histopathologic analysis of retrieved thrombi associated with successful reperfusion after acute stroke thrombectomy", Stroke, 47, pp.3035~3037 (2016)
47. Duffy S, "Per-pass analysis of thrombus composition in patients with acute ischemic stroke undergoing mechanical thrombectomy", Stroke, 50, pp.1156~1163 (2019)
48. Albert J. Yoo, "Thrombectomy in Acute Ischemic Stroke: Challenges to Procedural Success", 대한뇌졸중영문학회지, 19(2), pp.121~130 (2017), 대한뇌졸중학회[DOI]
49. Gunning GM, "Clot friction variation with fibrin content; implications for resistance to thrombectomy", J Neurointerv Surg, 10, pp.34~38 (2018)
50. Kaesmacher J, "Risk of thrombus fragmentation during endovascular stroke treatment", AJNR Am J Neuroradiol, 38, pp.991~998 (2017)
51. Dobrocky T, "Thrombectomy of calcified emboli in stroke. Does histology of thrombi influence the effectiveness of thrombectomy?", J Neurointerv Surg, 10, pp.345~350 (2018)
52. Koge J, "Vessel wall injury after stent retriever thrombectomy for internal carotid artery occlusion with duplicated middle cerebral artery", World Neurosurg, 123, pp.54~58 (2019)
53. Funatsu N, "Vascular wall components in thrombi obtained by acute stroke thrombectomy : clinical significance and related factors", J Neurointerv Surg, 11, pp.232~236 (2019)
54. Horie N, "Impact of mechanical thrombectomy device on thrombus histology in acute embolic stroke", World Neurosurg, 132, pp.e418~e422 (2019)
55. Qureshi AI, "Histopathological characteristics of IV recombinant tissue plasminogen : resistant thrombi in patients with acute ischemic stroke", J Vasc Interv Neurol, 8, pp.38~45 (2016)
56. Krajíčková D, "Fibrin clot architecture in acute ischemic stroke treated with mechanical thrombectomy with stent-retrievers : cohort study", Circ J, 82, pp.866~873 (2018)
57. Denorme F, "ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in mice", Blood, 127, pp.2337~2345 (2016)
58. Coller BS, "Platelets and thrombolytic therapy", N Engl J Med, 322, pp.33~42 (1990)
59. Szabo S, "Increased fibrin specificity and reduced paradoxical thrombin activation of the combined thrombolytic regimen with reteplase and abciximab versus standard reteplase thrombolysis", Drugs Exp Clin Res, 30, pp.47~54 (2004)
60. Alexandrov AV, "Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator", Neurology, 59, pp.862~867 (2002)
61. Heo JH, "Immediate reocclusion following a successful thrombolysis in acute stroke : a pilot study", Neurology, 60, pp.1684~1687 (2003)
62. Qureshi AI, "Subacute recanalization and reocclusion in patients with acute ischemic stroke following endovascular treatment", Neurocrit Care, 10, pp.195~203 (2009)
63. Saqqur M, "Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment : a multicenter transcranial Doppler study", Stroke, 38, pp.69~74 (2007)
64. Nam HS, "Prediction of thrombus resolution after intravenous thrombolysis assessed by CT-based thrombus imaging", Thromb Haemost, 107, pp.786~794 (2012)
65. Kim YD, "Time-dependent thrombus resolution after tissue-type plasminogen activator in patients with stroke and mice", Stroke, 46, pp.1877~1882 (2015)
66. Choi MH, "Erythrocyte fraction within retrieved thrombi contributes to thrombolytic response in acute ischemic stroke", Stroke, 49, pp.652~659 (2018)
67. Collet JP, "Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis", Arterioscler Thromb Vasc Biol, 26, pp.2567~2573 (2006)
68. Varjú I, "Hindered dissolution of fibrin formed under mechanical stress", J Thromb Haemost, 9, pp.979~986 (2011)
69. Navi BB, "Ischemic stroke in cancer patients : a review of an underappreciated pathology", Ann Neurol, 83, pp.873~883 (2018)
70. Whitlock RP, "Antithrombotic and thrombolytic therapy for valvular disease : antithrombotic therapy and prevention of thrombosis, 9th ed : american college of chest physicians evidence-based clinical practice guidelines", Chest, 141, pp.e576S~e600S (2012)
71. Sack GH Jr, "Trousseau’s syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features", Medicine(Baltimore), 56, pp.1~37 (1977)
72. Navi BB, "Enoxaparin vs aspirin in patients with cancer and ischemic stroke : the TEACH pilot randomized clinical trial", JAMA Neurol, 75, pp.379~381 (2018)
73. Kwon I, "Thrombolytic effects of the snake venom disintegrin saxatilin determined by novel assessment methods : a FeCl3-induced thrombosis model in mice", PLoS One, 8, pp.e81165~ (2013)

관련 논문AI추천